However for most microbial products of high value, the screening is usually complex and tedious, and often may involve two or more steps, e.g., for antimicrobials. In some cases, it may be desirable to concentrate on a group of organisms expected to yield new products.
For example, the search for new antibiotics now focusses on rare Actinomycetes, i.e., Actinomycetes other than those belonging to the genus Streptomyces. Suitably designed specialized screening techniques may be used to detect compounds having various pharmacological activities other than antibiotics.



